NC

Nexthera Capital Portfolio holdings

AUM $120M
1-Year Est. Return 10.01%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+10.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$120M
AUM Growth
+$37.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$12.6M
2
+$7.21M
3
+$6.33M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$5.61M
5
CHRS icon
Coherus Oncology
CHRS
+$5.49M

Top Sells

1
+$9.5M
2
+$5.08M
3
+$4.18M
4
NVS icon
Novartis
NVS
+$3.83M
5
CBAY
Cymabay Therapeutics
CBAY
+$2.79M

Sector Composition

1 Healthcare 92.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICPT
1
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$12.1M 10.1%
152,441
+140,489
INSM icon
2
Insmed
INSM
$31.2B
$12.1M 10.04%
470,741
+186,478
BOLD
3
DELISTED
Audentes Therapeutics, Inc
BOLD
$11.1M 9.27%
294,013
+43,393
NBIX icon
4
Neurocrine Biosciences
NBIX
$13.4B
$7.8M 6.5%
92,380
+68,340
SRPT icon
5
Sarepta Therapeutics
SRPT
$2.26B
$7.65M 6.37%
50,317
+29,047
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
$7.49M 6.23%
142,305
+55,206
IMMU
7
DELISTED
Immunomedics Inc
IMMU
$7.27M 6.06%
524,140
+189,416
CHRS icon
8
Coherus Oncology
CHRS
$297M
$6.99M 5.82%
+316,316
ASND icon
9
Ascendis Pharma
ASND
$15B
$6.94M 5.78%
+60,266
PCRX icon
10
Pacira BioSciences
PCRX
$1B
$6.48M 5.4%
+149,086
URGN icon
11
UroGen Pharma
URGN
$1.1B
$6.36M 5.29%
176,866
+44,277
QURE icon
12
uniQure
QURE
$1.1B
$4.68M 3.9%
59,883
+21,083
AMRN
13
Amarin Corp
AMRN
$314M
$4.46M 3.72%
11,515
+4,080
ABBV icon
14
AbbVie
ABBV
$369B
$3.83M 3.19%
+52,681
BHVN
15
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.77M 3.14%
+86,165
VTRS icon
16
Viatris
VTRS
$17.1B
$1.95M 1.63%
+102,560
ITCI
17
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.86M 1.55%
+143,665
REGN icon
18
Regeneron Pharmaceuticals
REGN
$79.4B
$1.77M 1.48%
+5,668
MDGL icon
19
Madrigal Pharmaceuticals
MDGL
$12.2B
$1.62M 1.35%
15,423
+11,971
DERM
20
DELISTED
Dermira, Inc.
DERM
$1.32M 1.1%
+138,102
GILD icon
21
Gilead Sciences
GILD
$171B
$1.26M 1.05%
+18,697
ANAB icon
22
AnaptysBio
ANAB
$1.94B
$679K 0.57%
+12,026
AGN
23
DELISTED
Allergan plc
AGN
$560K 0.47%
3,347
-10,353
BMRN icon
24
BioMarin Pharmaceuticals
BMRN
$10.5B
– –
-8,250
EXEL icon
25
Exelixis
EXEL
$11.4B
– –
-90,356
1
2